La Fundació PCB Page

Portal de Transparència Active advertising Institutional information Economic, budgetary and asset management Contracts and agreements List of companies to which the foundation subcontracts services Grants awarded Staff Content update procedure...

The CNAG-CRG participates in a European project to improve medical assistance through interceptive medicine Blog Post

Scientists from the Centro Nacional de Análisis Genómico (CNAG-CRG), based in Barcelona Science Park and integrated to the Centre for Genomic Regulation (CRG) unites with hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united to revolutionize healthcare on the frame of LifeTime initiative. They are participating in two publications: a perspective article in the journal Nature and the LifeTime Strategic Research Agenda. They are now presenting how to improve leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.

 

IBEC and IRB Barcelona researchers receive funding from “La Caixa” for biomedical research Blog Post

Researchers from the Institute of Bioengineering of Catalonia (IBEC) and the Barcelona Institute for Biomedical Research (IRB) -based in the Barcelona Science Park- are part of the winning projects of the third Call for Applications Health Research Projects organized by “La Caixa ” Foundation, which this year allocates 18 million euros to 25 biomedical projects to tackle those diseases with the greatest global impact, such as cardiovascular, neurological, infectious and oncological.

Launch of the company Gate2Brain, based on novel technology developed at IRB Barcelona to transport drugs into the brain Blog Post

The Institute for Research in Biomedicine (IRB Barcelona), the University of Barcelona (UB) and the Sant Joan de Déu Research Institute (IRSJD)- Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel technology to transport drugs into the brain. The biotech, based in the Barcelona Science Park, is the second joint spin-off between IRB Barcelona and the UB to be funded by the Mind the Gap Programme run by the Botín Foundation.

 

IBEC researcher Pere Roca-Cusachs joins the European elite club in biology Blog Post

Pere Roca-Cusachs –group leader at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park and associate professor at the Faculty of Medicine of the University of Barcelona (UB)– has been chosen to join the European Molecular Biology Organization (EMBO), a prestigious network that brings together some of the most brilliant researchers in the world.

 

Vesismin introduces the Ultraviolet Germicidal Irradiation in leading hospitals Blog Post

The company Vesismin Health –present in the Barcelona Science Park and specialized in the development and commercialization of products for the control of infections in hospital environments– has introduced the advanced UVGI technology (Ultraviolet Germicidal Irradiation), in different hospitals in Spain. Its professional system for medical use, UV-360, produces germicidal ultraviolet radiation for comprehensive disinfection of rooms and is equipped with motion sensors that automatically interrupt operation when they detect a presence.

 

Ona Therapeutics raises €30M in Series A financing Blog Post

Ona Therapeutics –a spin-off from IRB Barcelona and ICREA, based in the Barcelona Science Park– announces today the closing of a €30 million Series A financing, the largest private funding round closed for a start-up in Spain. The financing will allow Ona Therapeutics to complete the pre-clinical development in a variety of tumor types and to move its lead candidate into first clinical studies in patients with metastatic cancer in 2023.

 

The European Union has granted the coordination of three European projects to IBEC Blog Post

The European Union has granted the coordination of three European projects to the Institute for Bioengineering of Catalonia (IBEC) to continue combining medicine, science and technology with the aim of improving people’s health. Among the milestones achieved in recent years by the experts of the Institute, based at the Barcelona Science Park, we can find the development of bioimplants enriched with stem cells or the generation of vascularized mini-kidneys that have helped identify a drug in clinical phase that blocks the effects of SARS-Co-V2.

 

EIT Health selects Droplite, Ninevah and Oxolife for Headstart program Blog Post

Droplite, Ninevah Therapeutics and Oxolife, presents at the Barcelona Science Park, are three of the 16 Spanish startups that will participate in Headstart, the program of the European Institute of Innovation and Technology in Health (EIT Health) that offers support and financing of up to 50,000 € because emerging companies develop their innovations within a unique ecosystem, which gives them access to financing, experts, contacts and knowledge.